|
|
 |
|
| Patent # |
U.S. Patents |
Date |
Title |
Inventor |
| 35. |
7,276,250 |
10/02/07 |
Sustained Release Formulations of Oxymorphone
|
A. Baichwal
H. Kao
T. McCall |
| 34. |
6,875,793 |
4/5/05 |
Once-A-Day Controlled-Release Sulfonylurea Formulation |
A. Baichwal
D. Bhagwat
D. Diehl |
| 33. |
6,726,930 |
4/27/04 |
Sustained Release Heterodisperse Hydrogel
Systems for Insoluble
Drugs
|
A. Baichwal |
| 32. |
6,709,677B2 |
3/23/04 |
Sustained Release Heterodisperse Hydrogel
Systems-Amorphous Drugs |
A. Baichwal |
| 31. |
6,689,386 |
2/10/04 |
Sustained-Release Matrix for High-Dose Insoluble Drugs |
A. Baichwal |
| 30. |
6,537,578B1 |
3/25/03 |
Once-A-Day Controlled Release
Sulfonylurea Formulation |
A.
Baichwal
D. Bhagwat
D. Diehl |
| 29. |
6,387,394B1 |
5/14/02 |
Controlled-Release Insufflation
Carrier
Carrier for Medicaments |
A. Baichwal
J. Staniforth |
| 28. |
6,245,356B1 |
6/12/01 |
Sustained-Release Heterodisperse Hydrogel Systems-Amorphous
Drugs |
A.
Baichwal |
| 27. |
6,245,355B1 |
6/12/01 |
Sustained-Release Matrix
for High-Dose Insoluble Drugs |
A. Baichwal |
| 26. |
6,136,343 |
10/24/00 |
Sustained-Release Heterodisperse Hydrogel Systems for
Insoluble Drugs |
A.
Baichwal |
| 25. |
6,093,420 |
7/25/00 |
Sustained-Release Matrix
for High-Dose Insoluble Drugs |
A. Baichwal |
| 24. |
6,056,977 |
5/2/00 |
Once-A-Day Controlled-Release Sulfonylurea Formulation |
D.
Bhagwat
D. Diehl
A. Baichwal |
| 23. |
6,048,548 |
4/11/00 |
Sustained-Release Heterodisperse
Hydrogel Systems-Amorphous Drugs |
A. Baichwal |
| 22. |
6,039,980 |
3/21/00 |
Sustained-Release Excipient |
A.
Baichwal |
| 21. |
5,958,456 |
9/28/99 |
Controlled-Release Formulation
(Albuterol) |
A. Baichwal
T. McCall |
| 20. |
5,846,563 |
12/8/98 |
Sustained-Release Heterodisperse Hydrogel Systems for
Insoluble Drugs |
A.
Baichwal |
| 19. |
5,773,025 |
6/30/98 |
Sustained-Release Heterodisperse
Hydrogel Systems-Amorphous Drugs |
A. Baichwal |
| 18. |
5,738,865 |
4/14/98 |
Controlled-Release Insufflation Carrier for Medicaments |
A.
Baichwal
J. Staniforth |
| 17. |
5,670,168 |
9/23/97 |
Agglomerated Hydrophilic
Complexes with Multi-Phasic Release Characteristics |
A. Baichwal
J. Staniforth |
| 16. |
5,667,801 |
9/16/97 |
Sustained-Release Heterodisperse Hydrogel Systems for
Insoluble Drugs |
A.
Baichwal |
| 15. |
5,662,933 |
9/2/97 |
Controlled-Release Formulation
(Albuterol) |
A. Baichwal
T. McCall |
| 14. |
5,612,053 |
3/18/97 |
Controlled-Release Insufflation Carrier for Medicaments |
A.
Baichwal
J. Staniforth |
| 13. |
5,554,387 |
9/10/96 |
Sustained-Release Heterodisperse
Hydrogel Systems for Insoluble Drugs |
A. Baichwal |
| 12. |
5,512,297 |
4/30/96 |
Sustained-Release Heterodisperse Hydrogel Systems and
Insoluble Drugs |
A.
Baichwal |
| 11. |
5,478,574 |
12/26/95 |
Agglomerated Hydrophilic
Complexes with Multi-Phasic Release Characteristics |
A. Baichwal
J. Staniforth |
| 10. |
5,472,711 |
12/5/95 |
Agglomerated Hydrophilic Complexes with Multi-Phasic
Release Characteristics |
A.
Baichwal
J. Staniforth |
| 9. |
5,455,046 |
10/3/95 |
Sustained-Release Heterodisperse
Hydrogel Systems for Insoluble Drugs |
A. Baichwal |
| 8. |
5,399,362 |
3/21/95 |
Once-A-Day Metoprolol Oral Dosage Form |
A.
Baichwal
T. McCall |
| 7. |
5,399,359 |
3/21/95 |
Controlled-Release Oxybutynin
Formulations |
A. Baichwal |
| 6. |
5,399,358 |
3/21/95 |
Sustained-Release Formulations for 24 Hour Release of
Metoprolol |
A.
Baichwal
J. Staniforth |
| 5. |
5,330,761 |
7/19/94 |
Bioadhesive Tablet for Non-Systemic
Use Products |
A. Baichwal |
| 4. |
5,169,639 |
12/8/92 |
Controlled-Release Verapamil Tablets |
A.
Baichwal
J. Staniforth |
| 3. |
5,135,757 |
8/4/92 |
Compressible Sustained-Release
Solid Dosage Forms |
A. Baichwal
J. Staniforth |
| 2. |
5,128,143 |
7/7/92 |
Sustained-Release Excipient and Tablet Formulation |
A.
Baichwal
J. Staniforth |
| 1. |
4,994,276 |
2/19/91 |
Directly Compressible Sustained-Release
Excipient |
A. Baichwal
J. Staniforth |
|
|
| |
  |
